New developments in mechanisms of obesity-induced hypertension: Role of adipose tissue

被引：49

作者：

Sharma A.M. ^{[1
]}

Engeli S. ^{[1
]}

Pischon T. ^{[1
]}

机构：

[1] Department of Nephrology and Hypertension, Franz-Volhard-Klinik, Universitätsklinikum Charité, 13125 Berlin

来源：

Current Hypertension Reports | 2001年 / 3卷 / 2期

关键词：

Adipose Tissue; Atrial Natriuretic Peptide; Angiotensinogen; Renal Sympathetic Nerve Activity; Nonesterified Fatty Acid;

D O I：

10.1007/s11906-001-0030-x

中图分类号：

学科分类号：

摘要：

Hypertension develops in almost 60% of obese individuals. Apart from the recent observation of obesity-associated structural changes in kidney structure that may lead to enhanced tubular sodium reabsorbtion, reports of paracrine and hormonal factors derived from adipose tissue have prompted speculations about the role of adipose tissue in the pathophysiology of obesity-induced hypertension. We summarize recent data on leptin's sympathoexcitatory actions, the possible influence of adipose tissue on atrial natriuretic peptide levels, and the formation of vasoactive substances, such as angiotensin II and nonesterified fatty acids, by adipocytes. The mechanisms discussed herein may contribute to the typical findings in obesity-induced hypertension, including volume expansion, sodium retention, enhanced sympathetic nervous system activity, increased activity of the systemic renin-angiotensin system, low atrial natriuretic peptide levels, and disturbed glucose and insulin metabolism. Together, these data strengthen the hypothesis that adipose tissue is potentially a major regulator of cardiovascular-renal function. Copyright © 2001 by Current Science Inc.

引用

页码：152 / 156

页数：4

共 50 条

[1]

Must A., Spadano J., Coakley E.H., Et al., The disease burden associated with overweight and obesity, JAMA, 282, pp. 1523-1529, (1999)

[2]

Mikhail N., Golub M.S., Tuck M.L., Obesity and hypertension, Prog Cardiovasc Dis, 42, pp. 39-58, (1999)

[3]

Hall J.E., Brands M.W., Henegar J.R., Mechanisms of hypertension and kidney disease in obesity, Ann N y Acad Sci, 892, pp. 91-107, (1999)

[4]

Fujiwara K., Hayashi K., Matsuda H., Et al., Altered pressurenatriuresis in obese Zucker rats, Hypertension, 33, pp. 1470-1475, (1999)

[5]

Dwyer T.M., Banks S.A., Alonso-Galicia M., Et al., Distribution of renal medullary hyaluronan in lean and obese rabbits, Kidney Int, 58, pp. 721-729, (2000)

[6]

Dobrian A.D., Davies M.J., Prewitt R.L., Et al., Development of hypertension in a rat model of diet-induced obesity, Hypertension, 35, pp. 1009-1015, (2000)

[7]

Rumantir M.S., Vaz M., Jennings G.L., Et al., Neural mechanisms in human obesity-related hypertension, J Hypertens, 17, pp. 1125-1133, (1999)

[8]

Huang W.C., Fang T.C., Cheng J.T., Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats, Hypertension, 32, pp. 249-254, (1998)

[9]

Antic V., Kiener-Belforti F., Tempini A., Et al., Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits, Am J Hypertens, 13, pp. 556-559, (2000)

[10]

Engeli S., Sharma A.M., Adipose-tissue derived factors and cardiovascular-renal dysfunction in obesity, Horm Metab Res, 32, (2000)

← 1 2 3 4 5 →